Updated results including quality of life of the phase III CAIRO3 study of the Dutch Colorectal Cancer Group (DCCG): Maintenance treatment with capecitabine and bevacizumab versus observation after induction treatment with chemotherapy and bevacizumab in metastatic colorectal cancer (mCRC)

EUROPEAN JOURNAL OF CANCER(2013)

引用 1|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要